Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MERUS LABS INTERNATIONAL INC T.MSL

"Merus Labs International Inc is a specialty pharmaceutical company. The Company acquires and licenses novel pharmaceutical products."


TSX:MSL - Post by User

Post by GoldBug024on Sep 16, 2016 3:34pm
100 Views
Post# 25246348

Could the insider buying be share buyback?

Could the insider buying be share buyback?Read July 4 release below. So then the insiderbuying could be share buyback?

TORONTO, ONTARIO – July 4, 2016 –Merus Labs International Inc. (“Merus” or the “Company”) (TSX: MSL, NASDAQ: MSLI) is pleased to announce that it has made the first of its regularly scheduled quarterly principal repayments under its new credit facility and to provide a general business update. "The fundamentals of our business are continuing to perform as expected and support our ability to generate strong, predictable cash flow" said Barry Fishman, Chief Executive Officer. “Our healthy free cash flow provides the Company with several strategic choices - rapidly paying down debt, acquiring more assets, declaring dividends, and/or executing on our share-buyback plan
<< Previous
Bullboard Posts
Next >>